Genomic Health Posts 21 Percent Revenue Growth for Q1

The firm's product sales climbed 23 percent as sales of its Oncotype DX tests increased year over year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories